Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05822752 |
|---|---|
| Brief Title: | Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC) (LIVIGNO-1) |
| First Submitted : | April 10, 2023 |
| First Submitted that Met QC Criteria : | April 10, 2023 |
| First Posted : | April 21, 2023 |
| Last Update Submitted that Met QC Criteria : | May 8, 2024 |
| Last Update Posted : | May 10, 2024 |